Explore / Peer-reviewed article
Peer-reviewed article

Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity.

Copa DiD, Erritzoe DiD, Giribaldi B, Nutt D, Carhart-Harris RiD, Tagliazucchi E

Journal of affective disordersFeb 27, 2024Argentina, United Kingdom, United States, Chile25 citationsDOI: 10.1016/j.jad.2024.02.089

Abstract

<h4>Background</h4>Psilocybin is a serotonergic psychedelic drug under assessment as a potential therapy for treatment-resistant and major depression. Heterogeneous treatment responses raise interest in predicting the outcome from baseline data.<h4>Methods</h4>A machine learning pipeline was implemented to investigate baseline resting-state functional connectivity measured with functional magnetic resonance imaging (fMRI) as a predictor of symptom severity in psilocybin monotherapy for treatment-resistant depression (16 patients administered two 5 mg capsules followed by 25 mg, separated by one week). Generalizability was tested in a sample of 22 patients who participated in a psilocybin vs. escitalopram trial for moderate-to-severe major depression (two separate doses of 25 mg of psilocybin 3 weeks apart plus 6 weeks of daily placebo vs. two separate doses of 1 mg of psilocybin 3 weeks apart plus 6 weeks of daily oral escitalopram). The analysis was repeated using both samples combined.<h4>Results</h4>Functional connectivity of visual, default mode and executive networks predicted early symptom improvement, while the salience network predicted responders up to 24 weeks after treatment (accuracy≈0.9). Generalization performance was borderline significant. Consistent results were obtained from the combined sample analysis. Fronto-occipital and fronto-temporal coupling predicted early and late symptom reduction, respectively.<h4>Limitations</h4>The number of participants and differences between the two datasets limit the generalizability of the findings, while the lack of a placebo arm limits their specificity.<h4>Conclusions</h4>Baseline neurophysiological measurements can predict the outcome of psilocybin treatment for depression. Future research based on larger datasets should strive to assess the generalizability of these predictions.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinDepression

Keywords

Predictive modelingMachine LearningFunctional ConnectivityTreatment Resistant DepressionResting-state FmriPsilocybin Therapy

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.